New award for cinacalcet HCL tablets with avkare, LLC. Period of performance is september 24TH, 2021 to september 23RD, 2022 with four one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79721D0047
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$2,542,904.80
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Avkare LLC for the supply of Cinacalcet HCL tablets. The contract has a $2,542,904.80 ceiling value and a period of performance from September 24, 2021 to September 23, 2022, with four one-year option periods.

The contract aims to provide an uninterrupted source of Cinacalcet HCL tablets in 30mg, 60mg, and 90mg strengths to support the healthcare needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). Avkare, a for-profit limited liability company, will distribute the pharmaceutical products through the VA's and DoD's respective Pharmaceutical Prime Vendor programs. This IDC award follows a pre-solicitation notice issued by the VA, which indicated the agency would competitively award a single contract for these medication requirements without any set-asides.

Transactions

Action Obligated Date
Other Administrative Action P00008 · Notification that contract 36E79721D0047 (cinacalcet HCL tablets) will fulfil the current option year 2 however, there will not be an option year 3. The current… $0
Supplemental Agreement for work within scope P00007 · Update to cost recovery fee (CRF) and submission of quarterly sales reports $0
Add Subcontract Plan P00006 · Update contract 36E79721D0047 subcontracting plan from 01/01/2024 - 12/31/2024. $0
Exercise an Option P00005 · Exercise of option year two for contract 36E79721D0047 for cinacalcet HCL tablets with price changes. Effective 09/24/2023-09/23/2024. $0
Other Administrative Action P00004 · Incorporation of drug supply chain security act (DSCSA) language into contract. $0
Add Subcontract Plan P00003 · Incorporation of 2023 small business subcontracting plan into contract. $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 with avkare LLC for cinacalcet HCL tablets. Period of performance for the option year is 9/24/2022 -… $0
Add Subcontract Plan P00001 · This modification is issued to incorporate avkare LLC's 2022 subcontracting plan effective for the period of january 1, 2022-december 31, 2022. $0
Original award $0

Quick answers

Who was awarded contract 36E79721D0047?

36E79721D0047 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on September 24, 2021.

How much is contract 36E79721D0047 worth?

36E79721D0047's own ceiling is $2,542,905.

Who can order from contract 36E79721D0047?

36E79721D0047 is a single award indefinite delivery contract.

Was contract 36E79721D0047 competed?

The extent of competition for 36E79721D0047 was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login